C-suite moves in Dutch life sciences, Q3 2026

Eight announced C-level moves at seven Dutch-headquartered pharma, biotech and medtech companies between July and September 2026: two listed-company CEO seats, two CMOs, a new chief AI officer. One page, built from public sources only, with the four patterns that matter if you are hiring into a leadership team in the Netherlands.

• All eight moves in one table: who left, who arrived and where they came from
• Why five of six permanent appointments went to external hires
• Which recent funding rounds and deals point to the next leadership hires
• How the quarter compares with the 48 moves we have tracked since January 2025